Singapore's Biodiversity Could Provide Potential Cures
by Jasmin Malik Chua, Jersey City, USA 
on 08. 1.07
Photo credit: Ashley Ringrose
With a paltry 5 percent of its land officially allocated to nature—and that's including golf courses—Singapore isn't exactly heralded as a hotbed of biodiversity. A local drug-discovery company, however, begs to differ.
MerLion Pharmaceuticals, backed by the National Parks Board, plans to tap into the island-nation's plants, animals, and microorganisms as potential sources of new drugs. While the commercial exploitation of genetic resources is a sore point of contention among many indigenous cultures, Singapore has proven far savvier—royalties from any successfully produced drug will be disbursed to the nation, as well. ::Channel NewsAsia
See also: ::Atmospheric Pollution Ads from Singapore, ::Singapore to Host Eco-Products Fair, and ::We'll believe it when we see it Dept: Landfill Island as Eco-Tourist Site
Thirsty for more? Check out these related articles:
- Invasive Species: When Small Creatures Do Big Damage
- Ashley Judd on The Last Patch of Green Earth
- Destroying Ecosytems is Bad Business, Big Companies Invest in Nature
- Scientists Search for Loch Ness Monster, Find 100,000 Golf Balls
- 5 Eco Newsletters You Should Subscribe To
- How to Go Green: Ultimate Guide
Comments ()
